References
| 1. |
FLOXIN
Otic, sNDA 20-799, Approved September
30, 2003. |
| 2. |
Based
on overall responses of twice-daily
ofloxacin-treated patients in Phase III
clinical trials (NDA 20-799). |
|
3. |
Goldblatt
EL, Dohar J, Nozza RJ, Nielsen RW, et
al. Topical ofloxacin versus systemic
amoxicillin/clavulanate in purulent
otorrhea in children with tympanostomy
tubes. Intl J Ped Otorhinolaryngol.
1998;46:91-101. |
|
4. |
Ohyama,
M, Furuta, S, Veno, K, et al. Ofloxacin
otic solution in patients with otitis
media: an analysis of drug
concentrations. Arch of Otolaryngol.
1999;125:337-340. |
|
5. |
Consensus
Panel, Hannley MT, Denneny JC, Holzer
SS. Otolaryngology-Head and Neck
Surgery. 2000;122(6):934-940. |
|
